CaRLO — Cancer Research Library Online

1

Unknown

The software architecture of telecommunication system for a nationwide trauma network

Engelmann,U. ; Weininger,R. ; Muench,H. ; [et al.]

International Journal of Computer Assisted Radiology and Surgery 479-480

add to mindlist on the mindlist

Details

Type of Publication: Proceeding

Deep Link: http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowProceeding.aspx%3fpublishedId=32628

Permalink

Signatur	Availability

Others were also interested in ...

DKFZ PUBLICATION

2

Unknown

Outcomeforschung nach Polytrauma - ein systematisches Review (2017)

Ritschel, M ; Andrich, S ; Gnass, I ; [et al.]

German Medical Science GMS Publishing House; Düsseldorf

In: Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2017); 20171024-20171027; Berlin; DOCWI37-674 /20171023/

add to mindlist on the mindlist

Details

Publication Date: 2017-10-23

Keywords: Patient-berichtete Outcomes ; Polytrauma ; Instrumente ; ddc: 610

Language: German

Type: conferenceObject

Permalink

Signatur	Availability

Others were also interested in ...

GERMAN MEDICAL SCIENCE

Fulltext

3

Unknown

Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: A multicenter randomized phase III study

Hartung,G. ; Hofheinz,R.D. ; Dencausse,Y. ; [et al.]

Onkologie 28 (6-7), 347-350

add to mindlist on the mindlist

Details

Keywords: CANCER ; SURVIVAL ; tumor ; Germany ; THERAPY ; TOXICITY ; FOLLOW-UP ; COHORT ; DRUG ; MONOCLONAL-ANTIBODY ; PATIENT ; murine ; colon ; treatment ; antibodies ; antibody ; GLYCOPROTEIN ; TRIAL ; COLON-CANCER ; MONOCLONAL-ANTIBODIES ; FLUOROURACIL ; folinic acid ; ONCOLOGY ; colon cancer ; overall survival ; ADJUVANT THERAPY ; SWITZERLAND ; methods ; PHASE ; monoclonal antibodies ; monoclonal antibody ; edrecolomab ; MONOCLONAL-ANTIBODY THERAPY ; stage II

Abstract: Background: In a phase III study recruiting patients with stage II colon cancer the effect of adjuvant therapy with edrecolomab, a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, was compared to observation alone. Patients and Methods: From January 1997 until July 2000 a total of 377 patients were postoperatively stratified according to tumor stage (T3 vs. T4) and center, and randomly allocated to either treatment with edrecolomab ( cohort A, n = 183) or observation ( cohort B, n = 194). Patients in cohort A received a total of 900 mg edrecolomab. The study was terminated prematurely because of discontinuation of drug supply in Germany. Results: 305 patients were eligible for the primary endpoint of overall survival and 282 patients for disease-free survival. After a median follow-up of 42 months overall survival and disease-free survival were not significantly different. Toxicity was mild. Conclusions: In the present study, postoperative adjuvant treatment with edrecolomab in patients with resected stage II colon cancer did not improve overall or disease-free survival

Type of Publication: Journal article published

PubMed ID: 15933423

Deep Link: http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowJournal.aspx%3fpublishedId=2157

Permalink

Signatur	Availability

Others were also interested in ...

DKFZ PUBLICATION

4

Unknown

Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide

Samel,S. ; Keese,M. ; Lux,A. ; [et al.]

Cancer Gene Therapy 13 (1), 65-73

add to mindlist on the mindlist

Details

Keywords: CANCER ; CANCER CELLS ; CELLS ; tumor ; CELL ; COMBINATION ; Germany ; IN-VIVO ; MICROSCOPY ; THERAPY ; VOLUME ; GENE ; gene therapy ; MICE ; ACTIVATION ; prognosis ; colon ; INJECTION ; treatment ; BREAST-CANCER ; PROMOTER ; genetics ; colorectal cancer ; COLORECTAL-CANCER ; chemotherapy ; CANCER-CELLS ; COLON-CANCER ; FLUORESCENCE ; GENE-THERAPY ; GREEN FLUORESCENT PROTEIN ; heredity ; CYP2B1 ; ifosfamide ; ACTIVATING CYTOCHROME-P450 ; cytochrome P450 ; ONCOLOGY ; colon cancer ; QUALITY-OF-LIFE ; ENZYME ; SULFATE ; HISTOLOGY ; COMPOUND ; CANCER-TREATMENT ; animal ; viability ; cytomegalovirus ; FORMULATION ; INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY ; ISOPHOSPHORAMIDE MUSTARD ; LAPAROSCOPIC FLUORESCENCE DIAGNOSIS ; peritoneal carcinomatosis ; TARGETED CHEMOTHERAPY

Abstract: The prognosis of peritoneal spread from gastrointestinal cancer and subsequent malignant ascites is poor, and current medical treatments available are mostly ineffective. Targeted chemotherapy with intraperitoneal prodrug activation may be a beneficial new approach. L293 cells were genetically modified to express the cytochrome P450 enzyme 2B1 under the control of a cytomegalovirus immediate early promoter. This CYP2B1 enzyme converts ifosfamide to its active cytotoxic compounds. The cells are encapsulated in a cellulose sulfate formulation (Capcell(TM)). Adult Balb/c mice were inoculated intraperitoneally with 1 x 10(6) colon 26 cancer cells, previously transfected with GFP to emit a stable green fluorescence, by injection into the left lower abdominal quadrant. Two or five day's later animals were randomly subjected to either i.p. treatment with ifosfamide alone or ifosfamide combined with microencapsulated CYP2B1-expressing cells. Peritoneal tumor volume and tumor viability were assessed 10 days after tumor inoculation by means of fluorescence microscopy, spectroscopy and histology. Early i.p. treatment with ifosfamide and CYP2B1 cells resulted in a complete response. Treatment starting on day 5 and single-drug treatment with ifosfamide resulted in a partial response. These results suggest that targeted i.p. chemotherapy using a combination of a prodrug and its converting enzyme may be a successful treatment strategy for peritoneal spread from colorectal cancer

Type of Publication: Journal article published

PubMed ID: 16096652

Deep Link: http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowJournal.aspx%3fpublishedId=3715

Permalink

Signatur	Availability

Others were also interested in ...

DKFZ PUBLICATION

5

Unknown

TKmed - Telekooperation zur Versorgung von Schwerverletzten (2013)

Staemmler, M ; Walz, M ; Weisser, G ; [et al.]

German Medical Science GMS Publishing House; Düsseldorf

In: GMDS 2013; 58. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS); 20130901-20130905; Lübeck; DOCAbstr.282 /20130827/

add to mindlist on the mindlist

Details

Publication Date: 2013-08-28

Keywords: ddc: 610

Language: German

Type: conferenceObject

Permalink

Signatur	Availability

Others were also interested in ...

GERMAN MEDICAL SCIENCE

Fulltext

6

Unknown

Kindertraumatologischer Kompetenzgewinn durch Telekooperation im Traumnetzwerk (2012)

Illing, P ; Sturm, J ; Ruchholtz, S

German Medical Science GMS Publishing House; Düsseldorf

In: Süddeutsche Tage der Kinder- und Jugendmedizin; 61. Jahrestagung der Süddeutschen Gesellschaft für Kinder- und Jugendmedizin und der Süddeutschen Gesellschaft für Kinderchirurgie und dem Berufsverband für Kinder- und Jugendärzte - Landesverband Bayern; 20120504-20120506; München; DOC12sgkjFV25 /20120411/

add to mindlist on the mindlist

Details

Publication Date: 2012-04-12

Keywords: ddc: 610

Language: German

Type: conferenceObject

Permalink

Signatur	Availability

Others were also interested in ...

GERMAN MEDICAL SCIENCE

Fulltext

7

Unknown

Prävention thermischer Verletzungen beim Kind (2016)

Bodenschatz, K ; Sturm, J

German Medical Science GMS Publishing House; Düsseldorf

In: 34. Jahrestagung der Deutschsprachigen Arbeitsgemeinschaft für Verbrennungsbehandlung (DAV 2016); 20160113-20160116; Berchtesgaden, Deutschland; DOC16dav79 /20160112/

add to mindlist on the mindlist

Details

Publication Date: 2016-01-13

Keywords: ddc: 610

Language: German

Type: conferenceObject

Permalink

Signatur	Availability

Others were also interested in ...

GERMAN MEDICAL SCIENCE

Fulltext

8

Unknown

Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer

Gerhardt,A. ; Usener,D. ; Keese,M. ; [et al.]

Cancer Letters 208 (2), 197-206

add to mindlist on the mindlist

Details

Keywords: CANCER ; EXPRESSION ; tumor ; carcinoma ; CELL ; Germany ; DISEASE ; DISEASES ; GENE ; GENES ; SAMPLE ; SAMPLES ; cell line ; TISSUE ; LINES ; PATIENT ; SERA ; ANTIGEN ; ANTIGENS ; SKIN ; CELL-LINES ; FREQUENCY ; FIELD ; FREQUENCIES ; RECOGNITION ; tumor antigens ; antibodies ; antibody ; TARGET ; colorectal cancer ; COLORECTAL-CANCER ; CELL-LINE ; LINE ; CANCER-PATIENTS ; CARCINOEMBRYONIC ANTIGEN ; RT-PCR ; IMMUNE-RESPONSE ; IMMUNOTHERAPY ; cancer-germline genes ; MAGE GENES ; MELANOMA PATIENTS ; NY-ESO-1 ; sero-reactivity ; TARGETS ; CANCER PATIENTS ; INTERFERON-GAMMA ; LOCATION ; CYTOLYTIC T-LYMPHOCYTES ; SERUM ; RECOMBINANT ; COLORECTAL-CARCINOMA ; TUMOR-ANTIGENS ; CARCINOMA PATIENTS ; CELL LYMPHOMA ; cTAGE ; GAGE ; MAGE

Abstract: The expression of 14 individual and two groups of tumor antigens was characterized for colorectal carcinoma by RT-PCR using 26 colorectal carcinoma specimens, eight cell lines, six samples of patients with inflammatory bowl diseases, and nine specimens from different locations of an individual patient with a metastasized rectal carcinoma. The most frequently detected mRNAs were MAGE-A1 (58%), GAGE-3-7 (54%), and cTAGE-5a (31%). At medium frequencies (12-19%) we found cTAGE-1, MAGE-A2, se57-1, RAGE-4, and GAGE-1,2,8, while other tumor antigens were expressed rarely (〈9%). 85% of the samples were positive for at least one of the most frequently expressed antigens. Using a secondary SEREX approach and sera of eight colorectal cancer patients we found reactive antibodies against recombinant cTAGE-l (2 sera), se57-1 (2), truncated GAGE (1), and MAGE-Al (1). We conclude that certain cancer-germline genes can be detected in colorectal cancer and might therefore be promising targets for immunotherapy. (C) 2003 Elsevier Ltd. All rights reserved

Type of Publication: Journal article published

PubMed ID: 15142679

Deep Link: http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowJournal.aspx%3fpublishedId=1128

Permalink

Signatur	Availability

Others were also interested in ...

DKFZ PUBLICATION

9

Unknown

Ileus secondary to wireless capsule enteroscopy

Magdeburg,R. ; Riester,T. ; Hummel,F. ; [et al.]

International Journal of Colorectal Disease 21 (6), 610-613

add to mindlist on the mindlist

Details

Keywords: CANCER ; IRRADIATION ; Germany ; imaging ; DISEASE ; HISTORY ; DRUG ; SURGERY ; PATIENT ; treatment ; COMPUTED-TOMOGRAPHY ; ABNORMALITIES ; ANGIOGRAPHY ; SMALL-INTESTINE ; COMPLICATIONS ; INFLAMMATORY-BOWEL-DISEASE ; STENOSIS ; technique ; PUSH-ENTEROSCOPY ; DRUGS ; ENDOSCOPY ; BOWEL ; Crohn disease ; gastrointestinal bleeding ; jejunal stenosis ; wireless capsule enteroscopy

Abstract: Wireless capsule enteroscopy, being a novel, painless investigative technique, is reported to be significantly superior to push enteroscopy in its ability to find bleeding abnormalities in the small intestine. Here we report a case of acute jejunal obstruction following wireless capsule endoscopy. The patient had a 1-month history of gastrointestinal bleeding of unknown source. Further evaluation including gastroscopy and colonoscopy, angiography and computed tomography (angio-CT), and radio-labeled erythrocytes scan failed to reveal a source of bleeding. Therefore, wireless capsule enteroscopy was performed. Before capsule endoscopy, there was no clinical or imaging evidence of strictures or stenosis. At readmission it could be shown that there were two inflamed strictures of the small intestine. The capsule was detected at a stricture of the small intestine detected by abdominal ultrasonography and conventional computed tomography. The patient underwent a medical treatment with steroidal and other anti-inflammatory drugs for a total of 23 days and was discharged without complaints. Acute laparotomy after readmission with jejunal ileus proofed the capsule occluding two highly inflamed jejunal stenosis caused by Crohn disease. The present case demonstrates the potential for complications when wireless capsule enteroscopy is performed in the presence of intestinal strictures. Any history of inflammatory bowel disease, abdominal irradiation, cancer, obstruction, and abdominal surgery must be elicited in detail and may exclude the use of wireless capsule enteroscopy

Type of Publication: Journal article published

PubMed ID: 16411112

Deep Link: http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowJournal.aspx%3fpublishedId=3485

Permalink

Signatur	Availability

Others were also interested in ...

DKFZ PUBLICATION

10

Unknown

Stufenkonzept für eine bundesweite Plattform zur Telekooperation in Traumanetzwerken (2011)

Staemmler, M ; Walz, M ; Sturm, J

German Medical Science GMS Publishing House; Düsseldorf

In: Mainz//2011; 56. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), 6. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi); 20110926-20110929; Mainz; DOC11gmds432 /20110920/

add to mindlist on the mindlist

Details

Publication Date: 2011-09-20

Keywords: Telekooperation ; Traumanetzwerke ; DICOM ; ddc: 610

Language: German

Type: conferenceObject

Permalink

Signatur	Availability

Others were also interested in ...

GERMAN MEDICAL SCIENCE

Fulltext